Global Insulin Delivery Devices Market Analysis and Forecast 2017 - 2022

  • ID: 4387279
  • Report
  • Region: Global
  • 198 pages
  • Mordor Intelligence
1 of 4
The global market for insulin delivery devices has been estimated at USD XX million in 2016 and is projected to reach USD XX billion by 2021at a CAGR of X% during the forecast period from 2016 to 2021. Diabetes is a chronic disease caused due to the insufficient production or inappropriate use of insulin in the body. Insulin is responsible for the maintenance of sugar levels in the body and helps in the proper execution of all physiological and cellular activities. Insulin delivery devices are used to deliver insulin to the body and their market is widely expanding due to the high incidence of diabetes. Insulin administration is essential for type 1 and type 2 diabetic patients.

Global Insulin Delivery Devices Market- Market Dynamics

The report details several driving and restraining factors for the insulin delivery devices market. Some of them have been listed below.

Drivers

Rising prevalence of diabetes

Rise in prevalence of obesity

Increasing awareness about diabetic care

Technologically advanced insulin delivery devices

Restraints

High cost of the devices

Limited number of insulin producers

Hazards and risks associated with the drug delivery devices

Re-use of the needle could lead to bacterial growth on the needle risk of lipohypertrophy and risk of breaking the fine tip of the needle. The risk associated with jet injectors are the inaccuracy of insulin dosage and improper injection that can lead to altered absorption level of insulin in the blood stream and bruising.

The insulin delivery devices market is segmented on the basis of product type into jet injectors, syringes, insulin infusion pumps and insulin pens. The market is also segmented on the basis of mode of delivery into insulin inhalers, mouth sprays, pills and the patch. Insulin pens can be disposable and reusable.

Globally, the insulin drug delivery devices market is segmented into North America, Europe, Asia-Pacific and Rest of the World (RoW). North America dominates the market owing to the increasing prevalence of diabetes and obesity in this region. Europe is the second largest market for these devices. The Asia-Pacific market is growing at a faster pace owing to the increasing incidence of diabetes, rising geriatric population, government initiatives and rapidly rising awareness about the treatment of diabetes.

Many players in this market are trying to expand their product portfolio in order to top the global market. While some companies are entering the market by acquisitions, top companies are expanding their growth in this market by acquiring other companies. A few companies have adopted product innovation and new product launches as their key business strategy to ensure their dominance in this market.

Key Deliverables:

Market analysis for the insulin delivery devices market, with region-specific assessments and competition analysis on the global and regional scale.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the insulin delivery devices market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
2. Market Definition
3. Market drivers
4. Market Restraints
5. Value Chain Analysis of Delivery device Market
6. Device Market
7. Overview
7.1 Segmentation by Device types
7.1.1 Pen devices
7.1.2 Overview
7.1.3 Global Market (Market Size, Forecast, and CAGR)
7.1.3.1 Regional Market Segmentation (Market Size, Forecast, and CAGR)
7.1.3.1.1 North America
7.1.3.1.2 Europe
7.1.3.1.3 Asia Pacific
7.1.3.1.4 ROW
7.1.4 Insulin Pumps
7.1.5 Overview
7.1.6 Global Market (Market Size, Forecast, and CAGR)
7.1.6.1 Regional Market Segmentation (Market Size, Forecast, and CAGR)
7.1.6.1.1 North America
7.1.6.1.2 Europe
7.1.6.1.3 Asia-Pacific
7.1.6.1.4 ROW
7.1.7 Syringes
7.1.8 Overview
7.1.9 Global Market (Market Size, Forecast, and CAGR)
7.1.9.1 Regional Market Segmentation (Market Size, Forecast, and CAGR)
7.1.9.1.1 North America
7.1.9.1.2 Europe
7.1.9.1.3 Asia-Pacific
7.1.9.1.4 ROW
7.1.10 Transdermal Patch
7.1.10.1 Overview
7.1.10.2 Global Market (Market Size, Forecast, and CAGR)
7.1.10.3 Regional Market Segmentation (Market Size, Forecast, and CAGR)
7.1.10.3.1 North America
7.1.10.3.2 Europe
7.1.10.3.3 Asia-Pacific
7.1.10.3.4 ROW
8. Competitive Landscape
9. Future of the Insulin Delivery Device Market
9.1 Inhalers
9.2 Pills
10. Key Players in the Market
10.1 Becton Dickinson
10.2 Owen Mumford
10.3 Ypsomed
10.4 Medtronic
10.5 Insulet Corp
10.6 Novo Nordisk
11. Appendix
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll